HHS Extends Contract to Make ‘Humanized Mice’ With Aborted Baby Parts for Another 90 Days By Terence P. Jeffrey for CNS News
The Department of Health and Human Services says it has granted a second 90-day extension to a contract it has with the University of California at San Francisco that requires UCSF to make “humanized mice.”
These creatures are made by implanting mice with human tissues taken from late-term aborted babies.
The HHS’s multi-million-dollar contract with UCSF that requires the construction of these “humanized mice” creates a demand–driven by federal tax dollars–for tissue taken from late-term aborted babies. According to an estimate it has published on its website, the National Institutes of Health (which is a division of HHS) will spend $95 million this fiscal year alone on research that–like UCSF’s “humanized mouse” contract–uses human fetal tissue.
Under the new 90-day extension, the contract—which the government calls “Humanized Mouse Models for HIV Therapeutics Development”–will run through June 5.
HHS also is still in the process of conducting the “comprehensive review” it announced last September “of all research involving fetal tissue.”
That review was initiated to ensure that all federally funded research using human fetal tissue is consistent “with statutes and regulations governing such research, and to ensure the adequacy of procedures and oversight of this research in light of the serious regulatory, moral, and ethical considerations involved.”
“The UCSF contract has been issued another extension,” HHS said on Friday in response to questions from CNSNews.com about the contract and the review.
“We will provide an update on the review once it has concluded and as appropriate,” HHS said.
As CNSNews.com first reported on Oct. 17, 2018, the National Institutes of Health, which is part of HHS, originally signed its “humanized mouse” contract with UCSF on Dec. 6, 2013. The contract was for a one-year period and gave the government the option of renewing it for up to six additional one-year periods through Dec. 5, 2020.